Synthepor was founded in 2021 to provide Controlled Pore Glass support to the rapidly growing global oligonucleotide synthesis market.
Synthepor is a unique biotechnology company purpose-built to produce Controlled Pore Glass. The entire manufacturing process is done start to finish in a facility designed to produce the high-quality CPG.
Synthepor has the capacity to provide grams to kilograms of Controlled Pore Glass material and to scale with our customer's production and product growth.
Synthepor has decades of oligonucleotide and CPG production experiences making Synthepor the partner of choice for CPG.